Form 4: Director William M. Clancy Receives 200k Share Grant

Director William M. Clancy was granted 200,000 restricted shares of ChronoScale Corp common stock on May 14, 2026.

Summary

• Director William M. Clancy acquired 200,000 shares of common stock in ChronoScale Corp.
• The shares were granted as restricted stock units on May 14, 2026.
• The grant has a zero-dollar acquisition price.
• The total beneficial ownership for the director following this transaction is 200,000 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Retention mechanism established via a two-year vesting schedule.

Negatives

• Potential for future dilution of existing shareholders upon the vesting and issuance of these shares.

Risks

• Vesting is contingent upon the director's continuous service with the issuer.
• Market volatility could impact the future value of the equity grant.

Future Outlook

The shares vest in two equal tranches of 100,000 shares on the first and second anniversaries of the grant date, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and strategic alignment with shareholder interests.

Comparison to Industry Standards

• The use of restricted stock with multi-year vesting schedules is a standard practice for director compensation among publicly traded U.S. corporations.
• The two-year vesting period is relatively standard for director equity awards, though some companies utilize three-year schedules.

Stakeholder Impact

• Shareholders may experience minor dilution upon the vesting of these shares.

Next Steps

• Vesting of 100,000 shares on May 14, 2027.
• Vesting of 100,000 shares on May 14, 2028.

Key Dates

Keywords

ChronoScale Corp, CHRN, Form 4, Insider Trading, Equity Grant, Director Compensation